Follow us on LinkedIn
España
NTC
Novelty, Technology, Care
News & Events
-
NTC and I-MED Pharma form strategic partnership to bring the leading HA-based dry eye ointment to the United States market- Dec 15, 2021
NTC Srl and I-MED Pharma Inc announced today that I-DEFENSE®,… -
NTC and Aspen announce SAHPRA positive outcome for the fixed dose combination of levofloxacin and dexamethasone multidose eye drops- Nov 24, 2021
NTC granted the license and commercialisation rights of its patented… -
NTC and STADA announce commercial partnership for portfolio of ophthalmic products in the MENA region- Sep 07, 2021
NTC, international pharmaceutical company headquartered in Milan, Italy, and STADA,… -
NTC presents the Value report 2021 to its stakeholders- July 29, 2021
“Advanced scientific research and technology are the drivers of NTC’s…
PHARMACOVIGILANCE